title: Neurocognitive impairment associated with alcohol use disorders: implications for treatment.
abstract: Between 50% and 80% of individuals with alcohol use disorders experience mild to severe neurocognitive impairment. There is a strong clinical rationale that neurocognitive impairment is an important source of individual difference affecting many aspects of addiction treatment, but empirical tests of the direct influence of impairment on treatment outcome have yielded weak and inconsistent results. The authors address the schism between applied-theoretical perspectives and research evidence by suggesting alternative conceptual models of the relationship between neurocognitive impairment and addiction treatment outcome. Methods to promote neurocognitive recovery and ways in which addiction treatments may be modified to improve psychosocial adaptation are suggested. Specific suggestions for future research that may help clarify the complex relations between neurocognitive impairment and addiction treatment are outlined.
authors.affiliation: Center of Alcohol Studies, Rutgers University, Piscataway, New Jersey 08854-8001, USA. mebates@rci.rutgers.edu
authors.forename: Marsha E
authors.initials: ME
authors.lastname: Bates
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Bowden
authors.forename: Danielle
authors.initials: D
authors.lastname: Barry
mesh_terms: D020269:Alcoholic Neuropathy / Q000473:pathology / Q000503:physiopathology / Q000523:psychology*; D000437:Alcoholism / Q000473:pathology / Q000523:psychology* / Q000534:rehabilitation; D000818:Animals; D001921:Brain / Q000473:pathology; D003072:Cognition Disorders / Q000139:chemically induced* / Q000523:psychology*; D006801:Humans; D009482:Neurophysiology; D018377:Neurotransmitter Agents / Q000502:physiology; D010353:Patient Education as Topic; D016896:Treatment Outcome
chemical_list: D018377:Neurotransmitter Agents